Pages that link to "Q58668085"
Jump to navigation
Jump to search
The following pages link to Pharmacogenetics: ethical issues and policy options (Q58668085):
Displaying 18 items.
- Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report (Q24681986) (← links)
- Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boards (Q28079485) (← links)
- Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions (Q35148490) (← links)
- Ethical concerns related to developing pharmacogenomic treatment strategies for addiction (Q35286480) (← links)
- Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations (Q35575704) (← links)
- Eating disorders, serotonin transporter polymorphisms and potential treatment response (Q35676891) (← links)
- Pharmacogenetics and psychiatry (Q35707704) (← links)
- Pharmacogenetics and drug development: the path to safer and more effective drugs (Q35889605) (← links)
- Ethical implications in genetic counseling and family studies of the epilepsies (Q35893384) (← links)
- Diagnostics and biomarker development: priming the pipeline (Q36485635) (← links)
- A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics (Q36512012) (← links)
- Why personalized medicine will fail if we stay the course (Q36720898) (← links)
- Ancillary risk information and pharmacogenetic tests: social and policy implications (Q36814319) (← links)
- Attitudes of Health Care Professionals Toward Pharmacogenetic Testing (Q37881950) (← links)
- A review of consent practices and perspectives for pharmacogenetic testing (Q38929949) (← links)
- Delivering a pharmacogenetic service: is there a role for genetic counselors? (Q45421313) (← links)
- The Babel of genetic data terminology. (Q45936245) (← links)
- Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials (Q93080606) (← links)